Depression Online Assessment and Therapy

May 9, 2016 updated by: University of Zurich

Online Assessment for Therapy Expectation and Quality of Life and Online Therapy of Depression

One Aim of the current study is to better understand why some patients suffering from depression do not seek professional help by doctors but in the internet.

Furthermore patients with depression will receive Online Therapy for depression. Aim of this part of the study is to investigate whether quality of life changes accordingly to improvement of symptoms after online therapy.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

  • German speaking patients can register online. There will be no side visits.
  • After screening: patients which meet inclusion criteria and no exclusion criteria can take part in online therapy for depression.
  • After 12 weeks 2nd online survey. After this survey patients can use the program the following 6 months (follow-up)
  • After 6 months 3rd and last online-survey.
  • According to the aims of the study cross-sectional as well as longitudinal data will be obtained and analysed

Study Type

Interventional

Enrollment (Actual)

272

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

  • Switzerland
      • Zurich, Switzerland, 8091
        • University Hospital Zurich - only online recruitment

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 65 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • German language
  • depression at least slight according BDI (Beck depression inventory) and at least 2 weeks

Exclusion Criteria:

  • severe depression according BDI
  • suicidal ideation
  • alcohol or drug dependency
  • history of psychotic symptoms
  • history of bipolar disorder or previous mania
  • current in-patient care or semi-residential treatment

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Screening
  • Allocation: Randomized
  • Interventional Model: Single Group Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Other: no mail support
no mail support during follow-up
Other: no mail support
follow-up without mail support
Other: mail support
Other: Mail support
between post treatment and follow up two groups: one with unspecific mail support every 2 weeks one without

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change of Quality of life
Time Frame: at screening, post treatment (3 months) and follow-up (6 months after post)
WHOQol brev - WHO quality of life questionnaire short form
at screening, post treatment (3 months) and follow-up (6 months after post)

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
change of Sleep quality
Time Frame: screening, post treatment (3 months), follow-up(6 months after post)
Questionnaire PSQI - Pittsburgh sleep quality index
screening, post treatment (3 months), follow-up(6 months after post)
change of severity of depression
Time Frame: 3 time points screening, + 3 months + 6 months
patients receive mail support or not during follow up. Questionnaire: BDI - Beck Depression Inventory
3 time points screening, + 3 months + 6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
change of therapy expectation during online-therapy
Time Frame: 3 time points screening + 3 months + 6 months
therapy expectation at screening and after intervention. Questionnaire: PECHI - Psychotherapy Expectations, Concerns, and Hopes Inventory
3 time points screening + 3 months + 6 months
alexithymia
Time Frame: screening
influences on outcome? Questionnaire: TAS - Toronto Alexithymia Scale
screening
satisfaction with current and former therapies and influence on decision for online therapy
Time Frame: screening
adapted version of ZUF-8 (= "Zufriedenheitsfragebogen mit der Behandlung" english version CSQ- client satisfaction questionnaire) for different experiences with therapy (e.g. for depression, for other psychiatric illnesses)
screening
sense of coherence
Time Frame: screening
influencing outcome? measured with SOC-13 -Sense of Coherence Scale
screening
changes in sense of coherence
Time Frame: + 3 months after screening (post) and + 6 months after post
measured with SOC-13 does online-therapy helps to develop a better SOC?
+ 3 months after screening (post) and + 6 months after post
changes alexithymia
Time Frame: + 3 months after screening (post) , + 6 months after post
Trait and state characteristics of alexithymia in depression measured with TAS-20
+ 3 months after screening (post) , + 6 months after post

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

University of Zurich

Collaborators

Makora

Investigators

  • Principal Investigator: S Weidt, MD, USZ, UZH

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Helpful Links

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

April 1, 2014

Primary Completion (Actual)

March 1, 2016

Study Completion (Actual)

March 1, 2016

Study Registration Dates

First Submitted

April 4, 2014

First Submitted That Met QC Criteria

April 9, 2014

First Posted (Estimate)

April 11, 2014

Study Record Updates

Last Update Posted (Estimate)

May 10, 2016

Last Update Submitted That Met QC Criteria

May 9, 2016

Last Verified

May 1, 2016

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • ICBT
  • 2013-0542 (Other Identifier: KEK Zurich CH)

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Depression

Clinical Trials on no mail support

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Kuwait

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe